You are here:Home-Antibodies & Recombinant Proteins-Biosimilar Antibody

Request The Product List ofBiosimilar Antibody Biosimilar Antibody

Cat. No. Product Name CAS No. Information
PC-60125

CC-885

1010100-07-8 CC-885 (CC 885, CC885) is a novel E3 ligase cereblon (CRBN) modulator with potent anti-tumour activity mediated through the degradation of GSPT1.
PC-60116

VH-032

1448188-62-2 VH-032 (VHL ligand 1) is a VHL ligand for PROTAC and potent, small molecule inhibitor of the VHL/HIF-1α interaction with Kd of 185 nM..
PC-60115

VHL Ligand 3 (VH032-Boc)

1448189-98-7 (S,R,S)-AHPC-Boc (VH032-Boc) is a ligand used in the recruitment of the von Hippel-Lindau (VHL) protein and PROTAC technology.
PC-Ab1118

Camrelizumab

1798286-48-2 Camrelizumab (HR 301210, INCSHR 1210, SHR 1210) is a humanised high-affinity IgG4-kappa monoclonal antibody that targets the programmed cell death protein 1 (PD-1), binds PD-1 at a high affinity of 3 nM and inhibits the binding interaction of PD-1 and PD-L1 with an IC50 of 0.70 nM. Camrelizumab blocks the binding of PD-1, expressed on activated T lymphocytes, B cells and natural killer (NK) cells, to its ligands programmed cell death ligand 1 (PD-L1), overexpressed on certain cancer cells, and p
PC-Ab1117

Girentuximab

916138-87-9 Girentuximab (G250) is a monoclonal antibody (mAb) for targeting CA IX, a cell surface glycoprotein ubiquitously expressed in clear cell renal cell carcinoma (ccRCC). Carbonic anhydrase IX (CA IX) is the most widely expressed gene in response to hypoxia. Its crucial role in intracellular pH maintenance represents the means by which cancer cells adapt to the toxic conditions of the extracellular milieu..
PC-Ab1116

Anti-mouse PD-1 (Mouse IgG1 D265A mutation)

Binds to PD-1, blocks PD-1 interaction with PD-L1 and PD-L2, Mouse IgG1 D265A mutation..
PC-Ab1115

Sacituzumab

Sacituzumab is a human Trop-2 mAB that targets the Trop-2 protein and attaches to it. Sacituzumab govitecan is an antibody–drug conjugate composed of an antibody targeting the human trophoblast cell-surface antigen 2 (Trop-2), which is expressed in the majority of breast cancers, coupled to SN-38 (topoisomerase I inhibitor) through a proprietary hydrolyzable linker..

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com